School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
BMC Biotechnol. 2011 Oct 18;11:95. doi: 10.1186/1472-6750-11-95.
The glycosylation of recombinant proteins can be altered by a range of parameters including cellular metabolism, metabolic flux and the efficiency of the glycosylation process. We present an experimental set-up that allows determination of these key processes associated with the control of N-linked glycosylation of recombinant proteins.
Chinese hamster ovary cells (CHO) were cultivated in shake flasks at 0 mM glutamine and displayed a reduced growth rate, glucose metabolism and a slower decrease in pH, when compared to other glutamine-supplemented cultures. The N-linked glycosylation of recombinant human chorionic gonadotrophin (HCG) was also altered under these conditions; the sialylation, fucosylation and antennarity decreased, while the proportion of neutral structures increased. A continuous culture set-up was subsequently used to understand the control of HCG glycosylation in the presence of varied glutamine concentrations; when glycolytic flux was reduced in the absence of glutamine, the glycosylation changes that were observed in shake flask culture were similarly detected. The intracellular content of UDP-GlcNAc was also reduced, which correlated with a decrease in sialylation and antennarity of the N-linked glycans attached to HCG.
The use of metabolic flux analysis illustrated a case of steady state multiplicity, where use of the same operating conditions at each steady state resulted in altered flux through glycolysis and the TCA cycle. This study clearly demonstrated that the control of glycoprotein microheterogeneity may be examined by use of a continuous culture system, metabolic flux analysis and assay of intracellular nucleotides. This system advances our knowledge of the relationship between metabolic flux and the glycosylation of biotherapeutics in CHO cells and will be of benefit to the bioprocessing industry.
重组蛋白的糖基化可通过一系列参数改变,包括细胞代谢、代谢通量和糖基化过程的效率。我们提出了一种实验设置,可用于确定与控制重组蛋白的 N 连接糖基化相关的这些关键过程。
在无谷氨酰胺的摇瓶中培养中国仓鼠卵巢(CHO)细胞时,与其他补充谷氨酰胺的培养物相比,细胞生长速度、葡萄糖代谢和 pH 值下降速度较慢。在这些条件下,重组人绒毛膜促性腺激素(hCG)的 N 连接糖基化也发生了改变;唾液酸化、岩藻糖化和触角减少,而中性结构的比例增加。随后使用连续培养装置来了解在不同谷氨酰胺浓度存在下 hCG 糖基化的控制;当无谷氨酰胺时降低糖酵解通量时,在摇瓶培养中观察到的糖基化变化也被类似地检测到。细胞内 UDP-GlcNAc 的含量也减少了,这与 hCG 上附着的 N 连接聚糖的唾液酸化和触角减少相关。
代谢通量分析的使用说明了稳态多重性的情况,即在每个稳态下使用相同的操作条件会导致糖酵解和 TCA 循环的通量改变。这项研究清楚地表明,使用连续培养系统、代谢通量分析和细胞内核苷酸测定,可以检查糖蛋白微不均一性的控制。该系统提高了我们对 CHO 细胞中代谢通量与生物治疗剂糖基化之间关系的认识,并将有益于生物加工行业。